Skip to main content
Log in

Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The present report illustrates the clinical and biochemical outcome in two amiodarone iodine-induced thyrotoxicosis (AlIT) patients submitted to plasmapheresis. Amiodarone was discontinued, and treatment with MMI (40 mg/day) was started. In addition, patients were submitted to two sessions of plasma-exchange, with a one-day interval between the two session. In both patients serum total T3 (TT3) and free T3 (FT3) concentrations decreased promptly but in contrast to the serum TT3, FT3 levels remained steadily above the normal range. A similar behaviour was observed for total T4 and free T4 plasma concentrations. Interestingly, a clearcut clinical amelioration was observed in both patients even before a reduction of circulating free thyroid hormone concentrations could be documented. In conclusion, our experience indicates that plasmapheresis may be useful in order to obtain a rapid amelioration of severe clinical picture of thyrotoxicosis, but cannot be considered as a definite therapy in AIIT. It should be considered that plasmapheresis is not devoid of risks and is also a very expensive procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brennan M.D., van Harden J.A., Carney J.A. Amiodarone-associated thyrotoxicosis (AAT); experience with surgical management. Surgery 102: 1062, 1987.

    CAS  PubMed  Google Scholar 

  2. Merha A., Widerhorn J., Lopresti J., Rahimtoola S.H. Amiodarone-induced hyperthyroidism: thyroidectomy under local anesthesia. Am. Heart J. 122: 1160, 1991.

    Article  Google Scholar 

  3. Jonckheer M.H., Blockx P., Kaivers R., Wyffels G. Hyperthyroidism as possible complication of the treatment of ischemic heart disease with amiodarone. Acta Cardiol. 28: 192, 1973.

    CAS  PubMed  Google Scholar 

  4. Wimpfheimer L, Staubli M., Schadelin J., Studer H. Prednisone in amiodarone-induced thyrotoxicosis. Br. Med. J. 284: 1835, 1982.

    Article  CAS  Google Scholar 

  5. Leger A.F., Massin J.P., Laurent M.F., Vencens M., Auriol M., Helall O.B., Chomette G., Savoie J.C. Iodine-induced thyrotoxicosis: analysis of eighty-five consecutive cases. Eur. J. Clin. Invest. 14: 449, 1984.

    Article  CAS  PubMed  Google Scholar 

  6. Brussolle C, Ducottet X., Martin C, Barbier Y., Bornet G., Noel G., Orgiazzi J. Rapid effectiveness of prednisone and thionamides combined theraphy in severe amiodarone iodine-induced thyrotoxicosis. Comparison of two groups of patients with apparently normal thyroid gland. J. Endocrinol. Invest. 12: 37, 1989.

    Google Scholar 

  7. Uzzan B., Pussard E., Leon A., Bekhechi D., Krivitzky A., Modigliani E., Perret G., Vassy R., Berdeaux A., Giudicelli J.F. The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis. Br. J. Clin. Pharmacol. 31: 371, 1991.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Preuschof L., Keller F., Bogner U., Reuter E., Offerman G. Plasma exchange and hepoperfusion in iodine-induced thyrotoxicosis. Blood Purif 9: 164, 1991.

    Article  CAS  PubMed  Google Scholar 

  9. Romelli P.B., Pennisi F., Vancheri L. Measurement of free thyroid hormones in serum by column absorption chromatography and radioimmunoassay. J. Endocrinol. Invest 2: 25, 1979.

    CAS  PubMed  Google Scholar 

  10. Martino E., Safran M., Aghini-Lombardi F., Rajatanavin R., Lenziardi M., Fay M., Pacchiarotti A., Aronin N., Macchia E., Haffajee C., Odoguardi L., Love J., Bigalli A., Baschieri L., Pinchera A., Braverman L.E. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann. Intern. Med. 28: 101, 1984.

    Google Scholar 

  11. Martino E., Aghini-Lombardi F., Mariotti S., Lenziardi M., Baschieri L., Braverman L.E., Pinchera A. Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium Perchlorate and methimazole. J. Endocrinol. Invest. 9: 201, 1986.

    CAS  PubMed  Google Scholar 

  12. Martino E., Aghini-Lombardi F., Mariotti S., Bartalena L., Braverman L.E., Pinchera A. Amiodarone: a common source of iodine-induced thyrotoxicosis. Horm. Res. 26: 158,1987.

    Article  CAS  PubMed  Google Scholar 

  13. Editorial. Potassium Perchlorate and aplastic anemia. Br. Med. J. 1: 1520, 1961.

    Article  Google Scholar 

  14. Barzilai D., Sheinfeld M. Fatal complications following use of potassium Perchlorate in thyrotoxicosis. Report of two cases and a review of the literature. Isr. J. Med. Sci. 2: 453, 1961.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aghini-Lombardi, F., Mariotti, S., Fosella, P.V. et al. Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole. J Endocrinol Invest 16, 823–826 (1993). https://doi.org/10.1007/BF03348934

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348934

Key-words

Navigation